“The whole is greater than the sum of its parts.” What Aristotle probably meant philosophically can certainly be applied to business and science as well. Genomics, for example, is an interdisciplinary field of research which revolves around the analysis and synthesis of DNA sequences of a genome – all of the genes of an individual. The US American GENEWIZ corporation has successfully focused on this particular research field since 1999.
Life sciences venue Saxony is a region where about 350 biotechnology, pharmaceutical, and medical technology companies cooperate successfully with more than 30 research institutions and develop cutting edge, pioneering solutions for diagnostics and treatment at a top international level.
Here, in one of Germany’s most dynamic life sciences regions, Leipzig is a primary hot spot. It is home to BIO CITY, one of the most modern centers for biotechnology and biomedicine in all of Germany.
This is the creative environment in which GENEWIZ is now setting up its European headquarters. As a leading global provider of genomic services, the company operates labs in the USA, China, Germany, the United Kingdom, and Japan. At those locations, GENEWIZ is already a partner to numerous top-notch academic, pharmaceutical, and biotech facilities as well as innovative startups. Just recently, GENEWIZ established a high-tech lab with state-of-the-art sequencing platforms and lab automation technologies in Leipzig. It is located in the former hospital of the German Federal Armed Forces in Leipzig-Wiederitzsch. Here, the company is currently investing approx. 5 million euros. About 30 new, highly qualified jobs have already been created – this number is to be increased to around 50 by the end of 2019.